-
301
Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis
Published 2020-01-01“…Settings and Design: This was cross sectional case control study by the Departments of Biochemistry and Rheumatology and clinical immunology. Subjects and Methods: A total of 61 RA cases and 20 healthy controls were included. …”
Get full text
Article -
302
Inborn Errors of Immunity Presenting with Early-Onset Severe Atopy
Published 2025-01-01Get full text
Article -
303
-
304
-
305
-
306
-
307
-
308
Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis
Published 2014-01-01Get full text
Article -
309
The Hereditary Hyperferritinemia-Cataract Syndrome in 2 Italian Families
Published 2013-01-01Get full text
Article -
310
-
311
-
312
-
313
-
314
-
315
-
316
-
317
Anti‐retinal Autoantibodies in Hydroxychloroquine Eye Toxicity
Published 2025-01-01Get full text
Article -
318
An updated overview of Juvenile systemic sclerosis in a French cohort
Published 2025-02-01Get full text
Article -
319
Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome
Published 2025-02-01“…Yanping Gao,1,2,* Chen Chen,1,2,* Xijing Huang,2 Ya Liu,1 Zhou Zhou,1 Yan Pan1 1Department of Gastroenterology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China; 2Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yan Pan; Zhou Zhou, Sichuan Provincial People’s Hospital, 32 The First Ring Road West 2, Chengdu, Sichuan, 610072, People’s Republic of China, Email panyan2211@163.com; doublezhou2006@126.comIntroduction: Irritable bowel syndrome (IBS) is characterized by patients’ high level of suffering. …”
Get full text
Article -
320
Cellular therapies in rheumatic and musculoskeletal diseases
Published 2025-06-01Get full text
Article